Patient Guide: A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 11 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03758417
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE2

Find a Study Location Near You

This study is available at 11 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing, Beijing Municipality
  • Fuzhou, Fujian
  • Guandong, Guangzhou
  • • And 8 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily